AAAAAA

   
Results: 1-25 | 26-29
Results: 1-25/29
MANAGEMENT OF ANTIRETROVIRAL THERAPY FOR HIV-INFECTION - MODELING WHEN TO CHANGE THERAPY
Authors: DAMATO RM DAQUILA RT WEIN LM
Citation: Rm. Damato et al., MANAGEMENT OF ANTIRETROVIRAL THERAPY FOR HIV-INFECTION - MODELING WHEN TO CHANGE THERAPY, Antiviral therapy, 3(3), 1998, pp. 147-158
ANTIRETROVIRAL DRUG-RESISTANCE TESTING IN ADULTS WITH HIV-INFECTION -IMPLICATIONS FOR CLINICAL MANAGEMENT
Authors: HIRSCH MS CONWAY B DAQUILA RT JOHNSON VA BRUNVEZINET F CLOTET B DEMETER LM HAMMER SM JACOBSEN DM KURITZKES DR LOVEDAY C MELLORS JW VELLA S RICHMAN DD
Citation: Ms. Hirsch et al., ANTIRETROVIRAL DRUG-RESISTANCE TESTING IN ADULTS WITH HIV-INFECTION -IMPLICATIONS FOR CLINICAL MANAGEMENT, JAMA, the journal of the American Medical Association, 279(24), 1998, pp. 1984-1991
CCRS TRIANGLE-CCR5 HETEROZYGOSITY - A SELECTIVE PRESSURE FOR THE SYNCYTIUM-INDUCING HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PHENOTYPE/
Authors: DAQUILA RT SUTTON L SAVARA A HUGHES MD JOHNSON VA
Citation: Rt. Daquila et al., CCRS TRIANGLE-CCR5 HETEROZYGOSITY - A SELECTIVE PRESSURE FOR THE SYNCYTIUM-INDUCING HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PHENOTYPE/, The Journal of infectious diseases, 177(6), 1998, pp. 1549-1553
VARIABILITY AND PROGNOSTIC VALUES OF VIROLOGICAL AND CD4 CELL MEASURES IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1-INFECTED PATIENTS WITH 200-500 CD4 CELLS MM(3) (ACTG-175)/
Authors: LATHEY JL HUGHES MD FISCUS SA PI T JACKSON JB RASHEED S ELBEIK T REICHMAN R JAPOUR A DAQUILA RT SCOTT W GRIFFITH BP HAMMER SM KATZENSTEIN DA
Citation: Jl. Lathey et al., VARIABILITY AND PROGNOSTIC VALUES OF VIROLOGICAL AND CD4 CELL MEASURES IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1-INFECTED PATIENTS WITH 200-500 CD4 CELLS MM(3) (ACTG-175)/, The Journal of infectious diseases, 177(3), 1998, pp. 617-624
USE OF CHANGES IN PLASMA-LEVELS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA TO ASSESS THE CLINICAL BENEFIT OF ANTIRETROVIRAL THERAPY
Authors: MARSCHNER IC COLLIER AC COOMBS RW DAQUILA RT DEGRUTTOLA V FISCHL MA HAMMER SM HUGHES MD JOHNSON VA KATZENSTEIN DA RICHMAN DD SMEATON LM SPECTOR SA SAAG MS
Citation: Ic. Marschner et al., USE OF CHANGES IN PLASMA-LEVELS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA TO ASSESS THE CLINICAL BENEFIT OF ANTIRETROVIRAL THERAPY, The Journal of infectious diseases, 177(1), 1998, pp. 40-47
POPULATION PHARMACOKINETICS OF NEVIRAPINE, ZIDOVUDINE AND DIDANOSINE AFTER COMBINATION THERAPY IN HIV-INFECTED PATIENTS
Authors: ZHOU XJ SHEINER LB DAQUILA RT HUGHES MD HIRSCH MS FISCHL MA JOHNSON VA MYERS M SOMMADOSSI JP
Citation: Xj. Zhou et al., POPULATION PHARMACOKINETICS OF NEVIRAPINE, ZIDOVUDINE AND DIDANOSINE AFTER COMBINATION THERAPY IN HIV-INFECTED PATIENTS, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 39-39
MONITORING PLASMA HIV-1 RNA LEVELS IN ADDITION TO CD4(+) LYMPHOCYTE COUNT IMPROVES ASSESSMENT OF ANTIRETROVIRAL THERAPEUTIC RESPONSE
Authors: HUGHES MD JOHNSON VA HIRSCH MS BREMER JW ELBEIK T ERICE A KURITZKES DR SCOTT WA SPECTOR SA BASGOZ N FISCHL MA DAQUILA RT
Citation: Md. Hughes et al., MONITORING PLASMA HIV-1 RNA LEVELS IN ADDITION TO CD4(+) LYMPHOCYTE COUNT IMPROVES ASSESSMENT OF ANTIRETROVIRAL THERAPEUTIC RESPONSE, Annals of internal medicine, 126(12), 1997, pp. 929-938
EFFECTS OF ZIDOVUDINE-SELECTED HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE AMINO-ACID SUBSTITUTIONS ON PROCESSIVE DNA-SYNTHESIS AND VIRAL REPLICATION
Authors: CALIENDO AM SAVARA A AN D DEVORE K KAPLAN JC DAQUILA RT
Citation: Am. Caliendo et al., EFFECTS OF ZIDOVUDINE-SELECTED HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE AMINO-ACID SUBSTITUTIONS ON PROCESSIVE DNA-SYNTHESIS AND VIRAL REPLICATION, Journal of virology, 70(4), 1996, pp. 2146-2153
PROGNOSTIC VALUE OF PLASMA HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) RNA LEVELS IN PATIENTS WITH ADVANCED HIV-1 DISEASE AND WITH LITTLE OR NO PRIOR ZIDOVUDINE THERAPY
Authors: WELLES SL JACKSON JB YENLIEBERMAN B DEMETER L JAPOUR AJ SMEATON LM JOHNSON VA KURITZKES DR DAQUILA RT REICHELDERFER PA RICHMAN DD REICHMAN R FISCHL M DOLIN R COOMBS RW KAHN JO MCLAREN C TODD J KWOK S
Citation: Sl. Welles et al., PROGNOSTIC VALUE OF PLASMA HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) RNA LEVELS IN PATIENTS WITH ADVANCED HIV-1 DISEASE AND WITH LITTLE OR NO PRIOR ZIDOVUDINE THERAPY, The Journal of infectious diseases, 174(4), 1996, pp. 696-703
ASSOCIATION OF PLASMA HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA LEVEL WITH RISK OF CLINICAL PROGRESSION IN PATIENTS WITH ADVANCED INFECTION
Authors: COOMBS RW WELLES SL HOOPER C REICHELDERFER PS DAQUILA RT JAPOUR AJ JOHNSON VA KURITZKES DR RICHMAN DD KWOK S TODD J JACKSON JB DEGRUTTOLA V CRUMPACKER CS KAHN J
Citation: Rw. Coombs et al., ASSOCIATION OF PLASMA HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA LEVEL WITH RISK OF CLINICAL PROGRESSION IN PATIENTS WITH ADVANCED INFECTION, The Journal of infectious diseases, 174(4), 1996, pp. 704-712
HIV-1 CHEMOTHERAPY AND DRUG-RESISTANCE
Authors: DAQUILA RT
Citation: Rt. Daquila, HIV-1 CHEMOTHERAPY AND DRUG-RESISTANCE, Clinical and diagnostic virology, 3(4), 1995, pp. 299-316
HIV-1 DNA IN FIBROBLAST-CULTURES INFECTED WITH URINE FROM HIV-SEROPOSITIVE CYTOMEGALOVIRUS (CMV) EXCRETORS
Authors: MARGALITH M DAQUILA RT MANION DJ BASGOZ N BECHTEL LJ SMITH BR KAPLAN JC HIRSCH MS
Citation: M. Margalith et al., HIV-1 DNA IN FIBROBLAST-CULTURES INFECTED WITH URINE FROM HIV-SEROPOSITIVE CYTOMEGALOVIRUS (CMV) EXCRETORS, Archives of virology, 140(5), 1995, pp. 927-935
EX-VIVO EXPANSION OF CD4 LYMPHOCYTES FROM HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED PERSONS IN THE PRESENCE OF COMBINATION ANTIRETROVIRAL AGENTS
Authors: WILSON CC WONG JT GIRARD DD MERRILL DP DYNAN M AN DD KALAMS SA JOHNSON RP HIRSCH MS DAQUILA RT WALKER BD
Citation: Cc. Wilson et al., EX-VIVO EXPANSION OF CD4 LYMPHOCYTES FROM HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED PERSONS IN THE PRESENCE OF COMBINATION ANTIRETROVIRAL AGENTS, The Journal of infectious diseases, 172(1), 1995, pp. 88-96
PREVALENCE AND CLINICAL-SIGNIFICANCE OF ZIDOVUDINE RESISTANCE MUTATIONS IN HUMAN-IMMUNODEFICIENCY-VIRUS ISOLATED FROM PATIENTS AFTER LONG-TERM ZIDOVUDINE TREATMENT
Authors: JAPOUR AJ WELLES S DAQUILA RT JOHNSON VA RICHMAN DD COOMBS RW REICHELDERFER PS KAHN JO CRUMPACKER CS KURITZKES DR
Citation: Aj. Japour et al., PREVALENCE AND CLINICAL-SIGNIFICANCE OF ZIDOVUDINE RESISTANCE MUTATIONS IN HUMAN-IMMUNODEFICIENCY-VIRUS ISOLATED FROM PATIENTS AFTER LONG-TERM ZIDOVUDINE TREATMENT, The Journal of infectious diseases, 171(5), 1995, pp. 1172-1179
ZIDOVUDINE RESISTANCE AND HIV-1 DISEASE PROGRESSION DURING ANTIRETROVIRAL THERAPY
Authors: DAQUILA RT JOHNSON VA WELLES SL JAPOUR AJ KURITZKES DR DEGRUTTOLA V REICHELDERFER PS COOMBS RW CRUMPACKER CS KAHN JO RICHMAN DD
Citation: Rt. Daquila et al., ZIDOVUDINE RESISTANCE AND HIV-1 DISEASE PROGRESSION DURING ANTIRETROVIRAL THERAPY, Annals of internal medicine, 122(6), 1995, pp. 401-408
HIV-1 DRUG-RESISTANCE - MOLECULAR PATHOGENESIS AND LABORATORY MONITORING
Authors: DAQUILA RT
Citation: Rt. Daquila, HIV-1 DRUG-RESISTANCE - MOLECULAR PATHOGENESIS AND LABORATORY MONITORING, Clinics in laboratory medicine, 14(2), 1994, pp. 393-422
ALTERNATING VERSUS CONTINUOUS DRUG REGIMENS IN COMBINATION CHEMOTHERAPY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION IN-VITRO
Authors: MAZZULI T RUSCONI S MERRILL DP DAQUILA RT MOONIS M CHOU TC HIRSCH MS
Citation: T. Mazzuli et al., ALTERNATING VERSUS CONTINUOUS DRUG REGIMENS IN COMBINATION CHEMOTHERAPY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION IN-VITRO, Antimicrobial agents and chemotherapy, 38(4), 1994, pp. 656-661
RESISTANCE TO 2',3'-DIDEOXYCYTIDINE CONFERRED BY A MUTATION IN CODON-65 OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE
Authors: ZHANG D CALIENDO AM ERON JJ DEVORE KM KAPLAN JC HIRSCH MS DAQUILA RT
Citation: D. Zhang et al., RESISTANCE TO 2',3'-DIDEOXYCYTIDINE CONFERRED BY A MUTATION IN CODON-65 OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE, Antimicrobial agents and chemotherapy, 38(2), 1994, pp. 282-287
LONGITUDINAL ANALYSIS OF T-CELL RECEPTOR (TCR) GENE USAGE BY HUMAN IMMUNODEFICIENCY VIRUS-1 ENVELOPE-SPECIFIC CYTOTOXIC T-LYMPHOCYTE CLONESREVEALS A LIMITED TCR REPERTOIRE
Authors: KALAMS SA JOHNSON RP TROCHA AK DYNAN MJ NGO HS DAQUILA RT KURNICK JT WALKER BD
Citation: Sa. Kalams et al., LONGITUDINAL ANALYSIS OF T-CELL RECEPTOR (TCR) GENE USAGE BY HUMAN IMMUNODEFICIENCY VIRUS-1 ENVELOPE-SPECIFIC CYTOTOXIC T-LYMPHOCYTE CLONESREVEALS A LIMITED TCR REPERTOIRE, The Journal of experimental medicine, 179(4), 1994, pp. 1261-1271
HIV-1 DNA IN FIBROBLAST-CULTURES INFECTED WITH URINE FROM HIV-SEROPOSITIVE CYTOMEGALOVIRUS (CMV) EXCRETORS
Authors: MIRIAM M DAQUILA RT BECHTEL LJ SMITH BR KAPLAN JC HIRSCH MS
Citation: M. Miriam et al., HIV-1 DNA IN FIBROBLAST-CULTURES INFECTED WITH URINE FROM HIV-SEROPOSITIVE CYTOMEGALOVIRUS (CMV) EXCRETORS, Journal of acquired immune deficiency syndromes, 6(6), 1993, pp. 717-717
INTERACTIONS BETWEEN HIV-1 AND CYTOMEGALOVIRUS IN HUMAN OSTEOSARCOMA CELLS CARRYING BOTH VIRUSES
Authors: MARGALITH M MEDINA DJ HSIUNG GD SMITH BR DAQUILA RT KAPLAN JC BECHTEL L WANG MZ SKOLNIK PR HIRSCH MS
Citation: M. Margalith et al., INTERACTIONS BETWEEN HIV-1 AND CYTOMEGALOVIRUS IN HUMAN OSTEOSARCOMA CELLS CARRYING BOTH VIRUSES, AIDS research and human retroviruses, 9(6), 1993, pp. 519-527
ENZYMOLOGIC STUDIES OF HIV-1 AZT AND DDI RESISTANCE
Authors: CALIENDO AM ERON JJ CHOW YK DEVORE KM KAPLAN J DAQUILA RT
Citation: Am. Caliendo et al., ENZYMOLOGIC STUDIES OF HIV-1 AZT AND DDI RESISTANCE, Journal of cellular biochemistry, 1993, pp. 75-75
CYTOMEGALOVIRUS ANTIGENEMIA - CLINICAL CORRELATIONS IN TRANSPLANT RECIPIENTS AND IN PERSONS WITH AIDS
Authors: MAZZULLI T RUBIN RH FERRARO MJ DAQUILA RT DOVEIKIS SA SMITH BR THE TH HIRSCH MS
Citation: T. Mazzulli et al., CYTOMEGALOVIRUS ANTIGENEMIA - CLINICAL CORRELATIONS IN TRANSPLANT RECIPIENTS AND IN PERSONS WITH AIDS, Journal of clinical microbiology, 31(10), 1993, pp. 2824-2827
POL MUTATIONS CONFERRING ZIDOVUDINE AND DIDANOSINE RESISTANCE WITH DIFFERENT EFFECTS IN-VITRO YIELD MULTIPLY RESISTANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES IN-VIVO
Authors: ERON JJ CHOW YK CALIENDO AM VIDELER J DEVORE KM COOLEY TP LIEBMAN HA KAPLAN JC HIRSCH MS DAQUILA RT
Citation: Jj. Eron et al., POL MUTATIONS CONFERRING ZIDOVUDINE AND DIDANOSINE RESISTANCE WITH DIFFERENT EFFECTS IN-VITRO YIELD MULTIPLY RESISTANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES IN-VIVO, Antimicrobial agents and chemotherapy, 37(7), 1993, pp. 1480-1487
STANDARDIZED PERIPHERAL-BLOOD MONONUCLEAR CELL-CULTURE ASSAY FOR DETERMINATION OF DRUG SUSCEPTIBILITIES OF CLINICAL HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES
Authors: JAPOUR AJ MAYERS DL JOHNSON VA KURITZKES DR BECKETT LA ARDUINO JM LANE J BLACK RJ REICHELDERFER PS DAQUILA RT CRUMPACKER CS BALFOUR H ERICE A COOMBS R KATZENSTEIN D LATHEY J RICHMAN D MCINTOSH K RANGAN S REICHMAN R SCOTT W USSERY M ABRAMS L MCCUTCHAN F BURKE D GARDNER L ROBERTS C CHUNG R HICKS C SHELLIE E FOWLER A MERRITT L FUJIMURAJUSTICE M RUIZ N WAGNER K GAIL M
Citation: Aj. Japour et al., STANDARDIZED PERIPHERAL-BLOOD MONONUCLEAR CELL-CULTURE ASSAY FOR DETERMINATION OF DRUG SUSCEPTIBILITIES OF CLINICAL HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES, Antimicrobial agents and chemotherapy, 37(5), 1993, pp. 1095-1101
Risultati: 1-25 | 26-29